https://neuroinfo.it/archivio/ 2026-08-26T12:50:26+00:00 https://neuroinfo.it/news/parkinson-allasst-gaetano-pini-cto-di-milano-un-finanziamento-da-quasi-1-milione/ 2023-07-04T11:59:55+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Parkinson-ASST-Gateano-Pini.jpg https://neuroinfo.it/news/pubblicare-costa-troppo-il-caso-della-rivista-neuroimage/ 2023-07-04T12:03:40+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/NeuroImage.jpg https://neuroinfo.it/speciale/neurodegenerative/smartwatch-per-la-diagnosi-precoce-della-malattia-di-parkinson/ 2023-07-11T08:49:08+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Parkinson-smartwatch.jpg https://neuroinfo.it/speciale/neurodegenerative/demenza-rischio-piu-elevato-per-le-donne-con-fibrillazione-atriale/ 2023-07-14T09:22:00+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Demenza-donne-fibrillazione-atriale.jpg https://neuroinfo.it/congresso/sno/2023/scienze-neurologiche-ospedaliere-sno-appuntamento-a-firenze-per-il-62-congresso-nazionale/ 2023-07-14T09:23:43+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/62%C2%B0-Congresso-SNO.jpg https://neuroinfo.it/speciale/neurodegenerative/lecanemab-per-la-malattia-di-alzheimer-sin-e-sindem-pronte-a-raccogliere-la-sfida/ 2023-07-14T11:46:05+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Lecanemab-Alzheimer.jpg https://neuroinfo.it/speciale/epilessia/lassunzione-di-antiepilettici-in-gravidanza-impatta-sul-neurosviluppo-del-nascituro/ 2023-07-18T10:00:54+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Antiepilettici-in-gravidanza.jpg https://neuroinfo.it/speciale/neurodegenerative/microbiota-intestinale-e-diagnosi-di-alzheimer-preclinico-nuove-evidenze/ 2023-07-18T10:04:21+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Microbiota-Alzheimer.jpg https://neuroinfo.it/speciale/neurodegenerative/donanemab-per-la-malattia-di-alzheimer-i-risultati-del-trial-trailblazer-alz-2/ 2023-07-18T13:45:12+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Donanemab-Alzheimer.jpg https://neuroinfo.it/speciale/epilessia/epilessia-e-altri-disturbi-neurologici-dalla-who-un-piano-dazione-a-livello-globale/ 2023-07-24T09:02:13+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/WHO-epilessia.jpg https://neuroinfo.it/speciale/neurodegenerative/sclerosi-multipla-recidivante-remittente-aifa-approva-la-rimborsabilita-di-natalizumab-sottocute/ 2023-07-25T07:47:09+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/AIFA-natalizumab.jpg https://neuroinfo.it/speciale/epilessia/epilessia-in-europa-presentato-il-rapporto-headway-epilepsy/ 2023-07-25T08:13:13+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Epilessia-in-Europa.jpg https://neuroinfo.it/speciale/ictus/ictus-la-dieta-influisce-nel-20-30-dei-casi-contano-molto-di-piu-i-fattori-ereditari/ 2023-07-25T14:09:45+00:00 https://neuroinfo.it/wp-content/uploads/2023/07/Ictus-SNO.jpg https://neuroinfo.it/news/la-sottorappresentazione-delle-minoranze-nei-trial-clinici-sullalzheimer/ 2023-08-04T08:35:17+00:00 https://neuroinfo.it/wp-content/uploads/2023/08/Minoranze-trial-clinici-Alzheimer.jpg https://neuroinfo.it/speciale/emicrania-cefalee/trattare-lemicrania-senza-farmaci-con-un-neurostimolatore-il-progetto-delluniversita-di-pisa/ 2023-09-11T13:27:00+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/emicrania-neurostimolatore.jpg https://neuroinfo.it/speciale/emicrania-cefalee/terapia-dellemicrania-un-punto-sui-farmaci-innovativi/ 2023-09-12T07:23:12+00:00 https://neuroinfo.it/wp-content/uploads/2023/08/terapia-emicrania.jpg https://neuroinfo.it/news/traumi-cranici-negli-sport-ad-alto-contatto-nuove-evidenze-sul-flusso-sanguigno-cerebrale/ 2023-09-12T08:04:50+00:00 https://neuroinfo.it/wp-content/uploads/2023/08/Traumi-cranici-sport.jpg https://neuroinfo.it/interviste/traumi-cranici-negli-sport-ad-alto-contatto-dove-sta-andando-la-ricerca/ 2023-09-12T14:55:29+00:00 https://neuroinfo.it/wp-content/uploads/2023/08/Traumi-cranici-sport-intervista.jpg https://neuroinfo.it/speciale/neurodegenerative/farmaci-per-la-sla-e-la-miastenia-gravis-unanalisi-comparativa-nel-mondo-reale/ 2023-09-12T14:56:36+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Farmaci-SLA-Miastenia-gravis.jpg https://neuroinfo.it/news/benvenuti-su-neuroinfo/ 2023-09-13T07:51:22+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Neuroinfo_speciali.png https://neuroinfo.it/news/il-carlo-besta-di-milano-aderisce-alla-carta-della-qualita-e-della-sicurezza-delle-cure/ 2023-09-13T11:23:06+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Carlo-Besta-Carta.jpg https://neuroinfo.it/speciale/neurodegenerative/fondo-per-lalzheimer-e-le-demenze-vanacore-bloccarlo-sarebbe-deleterio/ 2023-09-13T11:25:13+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Fondo-Alzheimer-demenze.jpg https://neuroinfo.it/news/il-22-settembre-e-la-giornata-nazionale-della-neurologia-focus-sulla-prevenzione/ 2023-09-15T13:13:51+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Giornata-nazionale-della-neurologia.jpg https://neuroinfo.it/speciale/epilessia/la-prima-mappa-genetica-dellepilessia/ 2023-09-18T10:57:07+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/genetica-epilessia.jpg https://neuroinfo.it/congresso/sno/2023/62-congresso-sno-pasquale-palumbo-pronti-ad-affrontare-le-sfide-che-abbiamo-davanti/ 2023-09-18T13:12:37+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Congresso-SNO.jpg https://neuroinfo.it/speciale/ictus/intelligenza-artificiale-per-la-gestione-dellictus-nuove-evidenze/ 2023-09-19T10:51:07+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Intelligenza-artificiale-ictus.jpg https://neuroinfo.it/speciale/epilessia/sindromi-di-dravet-e-lennox-gastaut-nuovi-dati-su-fenfluramina-soluzione-orale/ 2023-09-20T12:57:23+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/fenfluramina-soluzione-orale.jpg https://neuroinfo.it/speciale/neurodegenerative/la-demenza-si-puo-prevenire-lelenco-dei-12-fattori-di-rischio-modificabili/ 2023-09-20T14:32:58+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/prevenzione-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/malattia-di-alzheimer-tra-ricerca-e-medicina-narrativa-il-progetto-remind/ 2023-09-21T10:18:03+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/REMIND.jpg https://neuroinfo.it/news/ce-una-nuova-definizione-di-salute-del-cervello/ 2023-09-26T11:18:26+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Definizione-salute-cervello.jpg https://neuroinfo.it/congresso/sno/2023/62-congresso-sno-vittorio-gallese-la-tecnologia-non-va-demonizzata-ma-i-giovani-vanno-educati/ 2023-09-27T10:47:00+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Gallese-tecnologia.jpg https://neuroinfo.it/speciale/ictus/conseguenze-emotive-e-comportamentali-dellictus-lappello-di-a-l-i-ce-italia-odv/ 2023-09-27T14:20:45+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/ictus-ansia.jpg https://neuroinfo.it/interviste/interazioni-cuore-cervello-dopo-un-ictus-dai-meccanismi-fisiopatologici-alla-gestione-clinica/ 2023-09-28T10:25:03+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/Cuore-cervello-ictus.jpg https://neuroinfo.it/wp-content/uploads/2023/08/cardioinfo_logo.png https://neuroinfo.it/congresso/sno/2023/come-trattare-lepilessia-nei-pazienti-con-tumori-cerebrali/ 2023-10-02T07:59:13+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Epilessia-tumori.jpg https://neuroinfo.it/speciale/epilessia/brivaracetam-aifa-approva-lestensione-alluso-sopra-i-due-anni/ 2023-10-02T11:03:09+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Brivaracetam.jpg https://neuroinfo.it/news/zilucoplan-per-la-miastenia-gravis-generalizzata-parere-positivo-del-chmp-dellema/ 2023-10-03T10:21:08+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Zilucomab-miastenia-gravis.jpg https://neuroinfo.it/speciale/epilessia/donne-con-epilessia-generalizzata-idiopatica-in-eta-fertile-trattamenti-a-confronto/ 2023-10-03T12:19:36+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/epilessia-giovanile.jpg https://neuroinfo.it/speciale/neurodegenerative/limportanza-della-real-world-evidence-nella-gestione-della-sclerosi-multipla/ 2023-10-04T12:28:57+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/carrozzella-.jpg https://neuroinfo.it/speciale/ictus/linsonnia-aumenta-il-richio-di-ictus/ 2023-10-05T08:23:44+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/insonnia-ictus.jpg https://neuroinfo.it/speciale/neurodegenerative/il-dna-mitocondriale-danneggiato-potrebbe-avere-un-ruolo-nella-patogenesi-del-parkinson/ 2023-10-10T08:47:58+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/DNA-mitocondriale-PArkinson.jpg https://neuroinfo.it/speciale/neurodegenerative/confermato-il-no-alluso-di-amx0035-per-il-trattamento-della-sla/ 2023-10-16T09:34:03+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/trattamento-SLA.jpg https://neuroinfo.it/speciale/ictus/una-nuova-prospettiva-per-il-recupero-funzionale-dopo-un-ictus/ 2023-10-16T14:19:06+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Ictus-mGlu5-.jpg https://neuroinfo.it/news/topiramato-in-gravidanza-dallema-nuove-misure-per-evitare-lesposizione/ 2023-10-17T07:10:20+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/topiramato-gravidanza.jpg https://neuroinfo.it/speciale/epilessia/immunomodulatori-per-il-trattamento-dellepilessia-focale-una-revisione-cochrane/ 2023-10-17T15:29:12+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/immunomodulatori.jpg https://neuroinfo.it/speciale/ictus/le-nuove-linee-guida-nice-alzano-lasticella-sulla-riabilitazione-post-ictus/ 2023-10-18T15:06:32+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/NICE-stroke.jpg https://neuroinfo.it/news/metilfenidato-per-ladhd-aifa-approva-la-rimborsabilita-per-gli-adulti-di-nuova-diagnosi/ 2023-10-20T12:21:31+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Metilfenidato-ADHD.jpg https://neuroinfo.it/speciale/neurodegenerative/malattia-di-alzheimer-alessandro-padovani-la-prevenzione-e-un-dovere/ 2023-10-25T09:16:41+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Alzheimer-PAdovani.jpg https://neuroinfo.it/interviste/ritorna-la-rivista-di-neurologia-un-classico-della-neurologia-italiana/ 2023-10-27T08:21:14+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/rivista-neurologia-2.jpg https://neuroinfo.it/speciale/neurodegenerative/progetto-interceptor-paolo-maria-rossini-ci-aspettiamo-risposte-scientifiche-di-interesse-straordinario/ 2023-10-31T09:17:31+00:00 https://neuroinfo.it/wp-content/uploads/2023/10/Interceptor.jpg https://neuroinfo.it/interviste/un-cadaver-lab-per-la-formazione-in-neurochirurgia/ 2023-11-02T09:10:25+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/Cadaver-Labjpg.jpg https://neuroinfo.it/speciale/neurodegenerative/lintelligenza-artificiale-al-servizio-della-prevenzione-della-demenza/ 2023-11-06T08:46:36+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/intelligeza-artificiale-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/sembra-che-covid-19-non-abbia-un-impatto-sullevoluzione-della-sclerosi-multipla/ 2023-11-06T11:04:43+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/COVID-19-sclerosi-multipla.jpg https://neuroinfo.it/speciale/neurodegenerative/brexpiprazolo-migliora-lagitazione-nei-pazienti-con-malattia-di-alzheimer/ 2023-11-07T10:05:26+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/brexipiprazolo.jpg https://neuroinfo.it/speciale/neurodegenerative/online-la-prima-mappa-dei-servizi-per-le-demenza/ 2023-11-14T08:59:04+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/mappa-servizi-demenza.jpg https://neuroinfo.it/interviste/progetto-moli-sani-e-neuromed-biobanking-centre-le-ricadute-di-interesse-neurologico/ 2023-11-15T11:25:45+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/biobanca.jpg https://neuroinfo.it/speciale/neurodegenerative/cura-per-lalzheimer-quanto-sono-affidabili-le-prove/ 2023-11-20T16:39:12+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/Alzheimer-prove.jpg https://neuroinfo.it/interviste/la-gestione-delladhd-in-italia-tra-limiti-strutturali-e-culturali/ 2023-11-27T11:00:18+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/ADHD-gestione.jpg https://neuroinfo.it/news/farmaci-antiepilettici-lalert-di-fda-su-levetiracetam-e-clobazam/ 2023-12-01T08:56:57+00:00 https://neuroinfo.it/wp-content/uploads/2023/12/FDA-epilessia.jpg https://neuroinfo.it/interviste/la-relazione-tra-ipertensione-e-danno-cerebrale-dallictus-alla-demenza/ 2023-12-07T08:41:31+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/ipertensione-danno-cerebrale-2.jpg https://neuroinfo.it/speciale/neurodegenerative/nuovi-trattamenti-per-la-malattia-di-alzheimer-cosa-dicono-le-evidenze/ 2023-12-07T15:35:46+00:00 https://neuroinfo.it/wp-content/uploads/2023/12/trattamenti-alzheimer.jpg https://neuroinfo.it/speciale/neurodegenerative/telemedicina-per-lassistenza-ai-pazienti-con-sclerosi-multipla-a-che-punto-siamo/ 2023-12-13T14:35:21+00:00 https://neuroinfo.it/wp-content/uploads/2023/12/EcoSM.jpg https://neuroinfo.it/speciale/neurodegenerative/sclerosi-multipla-un-banco-di-prova-per-telemedicina-e-nuovi-modelli-organizzativi/ 2023-12-20T09:22:23+00:00 https://neuroinfo.it/wp-content/uploads/2023/12/sclerosi-telemedicina.jpg https://neuroinfo.it/speciale/neurodegenerative/stimolazione-transcranica-a-corrente-diretta-tdcs-per-lalzheimer-nuove-evidenze/ 2024-01-08T14:02:15+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Stimolazione-tramscaranica-Alzheimer.jpg https://neuroinfo.it/news/la-condivisione-dei-dati-della-ricerca-qualcosa-si-muove/ 2024-01-09T08:49:41+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Condivisione-dei-dati.jpg https://neuroinfo.it/news/la-prima-linea-guida-nazionale-su-demenza-e-mild-cognitive-impairment/ 2024-01-11T08:59:47+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/linea-guida-demenza.jpg https://neuroinfo.it/speciale/emicrania-cefalee/il-nuovo-piano-cefalea-della-regione-emilia-romagna/ 2024-01-11T16:19:05+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Piano-cefalea-Emilia.jpg https://neuroinfo.it/interviste/adulti-con-adhd-alla-ricerca-di-una-diagnosi/ 2024-01-12T13:08:08+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/ADHD-adulti.jpg https://neuroinfo.it/news/dsm-5-tr-ancora-troppi-i-conflitti-di-interesse-non-dichiarati/ 2024-01-15T11:19:28+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Conflitti-di-interesse-DSM.jpg https://neuroinfo.it/speciale/epilessia/emicrania-cefalee/nuove-misure-precauzionali-sulluso-dei-farmaci-a-base-di-valproato/ 2024-01-15T14:00:42+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/valproato.jpg https://neuroinfo.it/news/la-meditazione-mindfulness-puo-aiutare-i-pazienti-con-emicrania/ 2024-01-18T14:08:22+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Mindfulness-emicrania.jpg https://neuroinfo.it/speciale/neurodegenerative/fondo-per-lalzheimer-e-le-demenze-quali-risultati-dal-primo-triennio-di-attivita/ 2024-01-22T16:07:18+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Fondo-demenze.jpg https://neuroinfo.it/news/disturbi-del-neurosviluppo-nei-bambini-nati-prematuri-uno-studio-di-coorte/ 2024-01-25T09:28:46+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Neurosviluppo-bambini-prematuri.jpg https://neuroinfo.it/news/pseudoefedrina-nuove-misure-per-ridurre-il-rischio-cerebrovascolare/ 2024-01-29T09:02:10+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/pseudoefedrina.jpg https://neuroinfo.it/speciale/neurodegenerative/miastenia-gravis-generalizzata-la-commissione-europea-autorizza-due-nuovi-trattamenti/ 2024-02-01T13:30:45+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Miastenia-gravis-nuovi-trattamenti.jpg https://neuroinfo.it/speciale/neurodegenerative/trattamenti-per-lalzheimer-biogen-rinuncia-ad-aducanumab/ 2024-02-01T14:54:36+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/aducanumab.jpg https://neuroinfo.it/news/dipendenza-da-videogiochi-sinpia-fondamentale-un-ruolo-attivo-dei-genitori/ 2024-02-05T10:44:31+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Gaming-idorder.jpg https://neuroinfo.it/speciale/ictus/isc24-ecco-la-lista-delle-late-breaking-science-sessions/ 2024-02-06T15:05:41+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Phoenix.jpg https://neuroinfo.it/news/ictus-dissezione-arteriosa-cervicale-e-infarto-miocardico-quale-relazione/ 2024-02-07T11:49:33+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/ictus-dissezione-infarto.jpg https://neuroinfo.it/news/ictus-nuovi-dati-sul-posizionamento-della-testa-dei-pazienti-in-attesa-di-trombectomia/ 2024-02-08T08:48:35+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/ISC24-ZODIAC.jpg https://neuroinfo.it/congresso/isc/2024/apixaban-vs-aspirina-nei-pazienti-con-ictus-criptogenico-e-cardiopatia-atriale-il-trial-arcadia/ 2024-02-08T13:02:33+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/ARCADIA.jpg https://neuroinfo.it/congresso/isc/2024/gestione-dellictus-ischemico-acuto-outcome-migliori-con-lintelligenza-artificiale/ 2024-02-09T14:42:37+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/ictus-intelligenza-artificiale.jpg https://neuroinfo.it/news/stimolazione-del-nervo-vago-per-la-riabilitazione-motoria-post-ictus/ 2024-02-09T14:47:21+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Stimolazione-nervo-vago-ictus.jpg https://neuroinfo.it/interviste/in-italia-la-poliomelite-non-esiste-piu-la-sindrome-post-polio-invece-si/ 2024-02-12T17:55:17+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/sindrome-post-polio.jpg https://neuroinfo.it/news/appello-della-sin-per-un-uso-responsabile-dei-pesticidi/ 2024-02-15T18:50:08+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/pesticidi.jpg https://neuroinfo.it/news/antonio-de-tanti-e-il-nuovo-presidente-della-sirn/ 2024-02-19T09:16:40+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/SIRN.jpg https://neuroinfo.it/speciale/neurodegenerative/nuove-prospettive-nella-malattia-di-parkinson-dalla-diagnosi-precoce-al-trattamento/ 2024-02-20T08:35:03+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/diagnosi-precoce-Parkinson.jpg https://neuroinfo.it/news/sildenafil-tadalafil-vardenafil-e-rischio-di-alzheimer-ce-una-relazione/ 2024-02-20T09:05:35+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Sildenafil.jpg https://neuroinfo.it/speciale/neurodegenerative/un-elmetto-pet-per-la-diagnosi-delle-patologie-neurodegenerative/ 2024-02-20T10:20:37+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Elmetto-PET.jpg https://neuroinfo.it/news/nuove-evidenze-sulla-relazione-tra-consumo-di-caffeina-ed-emicrania/ 2024-02-21T09:45:16+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Caffeina.jpg https://neuroinfo.it/speciale/epilessia/epilessie-rare-lice-la-diagnosi-precoce-e-fondamentale/ 2024-02-28T13:43:50+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/Epilessie-rare.jpg https://neuroinfo.it/speciale/neurodegenerative/la-memoria-delle-emozioni-un-docufilm-alla-scoperta-dellalzheimer/ 2024-03-02T11:40:28+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/La-memoria-delle-emozioni.jpg https://neuroinfo.it/wp-content/uploads/2024/03/locandina-evento-9-marzo-Il-paese-ritrovato.jpg https://neuroinfo.it/speciale/emicrania-cefalee/emicrania-gli-anticorpi-monoclonali-anti-cgrp-agiscono-anche-sullaura/ 2024-03-04T15:48:46+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/emicrania-aura.jpg https://neuroinfo.it/speciale/neurodegenerative/risultati-promettenti-per-frexalimab-nella-sclerosi-multipla-recidivante/ 2024-03-06T10:24:33+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/SM-flex.jpg https://neuroinfo.it/speciale/neurodegenerative/aperte-le-iscrizioni-alla-terza-edizione-del-corso-demenza-e-migranti/ 2024-03-06T14:27:19+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/Corso-demenza-migranti.jpg https://neuroinfo.it/news/ce-una-relazione-tra-autismo-e-inquinamento-atmosferico/ 2024-03-07T11:52:26+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/autismo-inquinamento.jpg https://neuroinfo.it/news/una-strategia-italiana-per-la-salute-del-cervello-la-sin-presenta-il-manifesto-one-brain-one-health/ 2024-03-13T15:17:44+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/Manifesto-SIN.jpg https://neuroinfo.it/news/lequita-al-centro-della-giornata-mondiale-del-sonno-2024/ 2024-03-15T08:47:36+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/Giornata-sonno.jpg https://neuroinfo.it/news/la-terapia-farmacologica-per-ladhd-potrebbe-ridurre-la-mortalita/ 2024-03-19T12:14:14+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/ADHD-mortalita.jpg https://neuroinfo.it/speciale/epilessia/farmaci-antiepilettici-in-gravidanza-e-rischio-di-autismo-nuove-evidenze/ 2024-03-29T13:08:00+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/Antiepilettici-autismo.jpg https://neuroinfo.it/news/fondo-da-cento-milioni-per-lautismo-un-passo-in-avanti-ma-senza-una-strategia-condivisa/ 2024-04-02T06:59:31+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/Fondo-autismo.jpg https://neuroinfo.it/speciale/neurodegenerative/il-delirium-e-un-fattore-di-rischio-per-linsorgenza-di-demenza/ 2024-04-09T08:31:23+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/delirium-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/agonisti-recettoriali-del-glp-1-per-il-trattamento-del-parkinson-nuovi-dati-su-lixisenatide/ 2024-04-16T06:42:31+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/lixisenatide-parkinson.jpg https://neuroinfo.it/news/le-condizioni-neurologiche-pesano-sempre-di-piu-sulla-salute-globale/ 2024-04-16T06:43:28+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/patologie-neurologiche-globale.jpg https://neuroinfo.it/speciale/neurodegenerative/parkinson-evidenze-a-favore-di-un-sistema-di-infusione-continua-di-levodopa-carbidopa/ 2024-04-16T06:44:01+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/levodopa-carbidopa-infusione.jpg https://neuroinfo.it/speciale/neurodegenerative/e-linquinamento-la-causa-della-malattia-di-parkinson/ 2024-04-16T06:46:36+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/inquinamento-parkinson-scaled.jpg https://neuroinfo.it/news/come-riconoscere-ed-evitare-i-predatory-journals/ 2024-04-29T11:02:23+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/Predatory-journals.jpg https://neuroinfo.it/speciale/neurodegenerative/sulla-relazione-tra-inquinamento-clima-e-patologie-neurologiche/ 2024-04-29T12:44:14+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/inquinamento.jpg https://neuroinfo.it/speciale/emicrania-cefalee/cefalee-in-italia-e-nel-mondo-epidemiologia-e-sfide-future/ 2024-04-30T11:38:03+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/Cefalee-nel-mondo.jpg https://neuroinfo.it/speciale/neurodegenerative/valutare-la-demenza-in-contesti-multiculturali-disponibile-la-traduzione-italiana-della-scala-rudas/ 2024-05-04T16:07:13+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/RUDAS-demenza.jpg https://neuroinfo.it/speciale/emicrania-cefalee/inibitori-di-pompa-protonica-e-rischio-di-emicrania-e-cefalea-quale-relazione/ 2024-05-10T13:36:11+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/PPI-micrnia.jpg https://neuroinfo.it/news/disturbo-motorio-funzionale-quando-la-diagnosi-diventa-unodissea/ 2024-05-13T08:07:54+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/Disturbo-motorio-funzionale.jpg https://neuroinfo.it/speciale/emicrania-cefalee/atogepant-per-il-trattamento-dellemicrania-episodica-i-risultati-del-trial-elevate/ 2024-05-20T15:22:12+00:00 https://neuroinfo.it/wp-content/uploads/2024/04/Atogepant-emicrania.jpg https://neuroinfo.it/speciale/neurodegenerative/sla-disponibile-in-italia-la-formulazione-orodispersibile-di-riluzolo/ 2024-05-20T15:22:31+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/riluzolo-orodispersibile.jpg https://neuroinfo.it/speciale/neurodegenerative/parkinson-approvata-la-rimborsabilita-di-foslevodopa-foscarbidopa-in-infusione-sottocutanea/ 2024-05-20T15:22:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/foslevodopa-foscarbidopa.jpg https://neuroinfo.it/speciale/neurodegenerative/un-nuovo-trattamento-per-la-sla-tofersen-riceve-il-parere-positivo-del-chmp/ 2024-05-20T15:23:13+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/tofersen-EMA.jpg https://neuroinfo.it/speciale/epilessia/midazolam-oromucosale-aifa-abolisce-nota-93-limitazioni-prescrizioni-carico-del-ssn/ 2024-05-20T15:23:34+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Midazolam.jpg https://neuroinfo.it/speciale/emicrania-cefalee/emicrania-il-chiarimento-dellaifa-sulla-compilazione-del-registro-di-galcanezumab/ 2024-05-20T15:23:59+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/AIFA-galcanezumab.jpg https://neuroinfo.it/news/gli-effetti-dellintelligenza-artificiale-sulla-vita-sociale-di-bambini-e-adolescenti/ 2024-05-24T09:39:11+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/intelligenza-artificiale-adolescenti-scaled.jpg https://neuroinfo.it/news/e-online-gastroinfo-per-un-aggiornamento-tempestivo-in-gastroenterologia-ed-epatologia/ 2024-05-28T22:15:22+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/Gastroinfo_card_social_2.png https://neuroinfo.it/congresso/sno/2024/appuntamento-a-bologna-per-il-63-congresso-nazionale-sno/ 2024-05-30T08:46:10+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/Congresso-SNO-2024.jpg https://neuroinfo.it/speciale/neurodegenerative/demenza-limpatto-dei-fattori-di-rischio-modificabili/ 2024-05-30T09:05:41+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/demenza-fattori.jpg https://neuroinfo.it/news/valutazione-della-performance-scolastica-nei-sopravvissuti-a-tumori-cerebrali-pediatrici/ 2024-06-03T07:46:39+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/performance-scolastica-tumori-pediatrici.jpg https://neuroinfo.it/congresso/sno/2024/le-sfide-della-neurologia-ospedaliera-e-il-ruolo-della-sno/ 2024-06-14T07:13:43+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Neurologia-ospedaliera.jpg https://neuroinfo.it/speciale/neurodegenerative/sclerosi-multipla-smoldering-neuroinflammation-e-accumulo-di-disabilita/ 2024-06-14T09:24:25+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Smoldering-Clerico.jpg https://neuroinfo.it/congresso/sno/2024/neuroradiologia-i-vantaggi-di-un-approccio-multidisciplinare/ 2024-06-17T07:14:06+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Neuroradiologia.jpg https://neuroinfo.it/congresso/sno/2024/sulla-collaborazione-tra-neurologi-e-cardiologi-dalla-stroke-unit-alla-prevenzione-secondaria/ 2024-06-20T07:26:42+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/cardiologi-neurologi.jpg https://neuroinfo.it/news/sla-ok-della-commissione-europea-per-limmissione-in-commercio-di-tofersen/ 2024-06-20T14:13:43+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/UE-tofersen.jpg https://neuroinfo.it/speciale/neurodegenerative/global-day-sla-notizie-incoraggianti-dalla-societa-italiana-di-neurologia/ 2024-06-20T14:25:25+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Global-day-SLA.jpg https://neuroinfo.it/congresso/sno/2024/la-multidisciplinarieta-al-centro-del-63-congresso-sno/ 2024-06-21T07:49:55+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Multidisciplinarieta-SNO.jpg https://neuroinfo.it/interviste/progressione-della-sclerosi-multipla-i-vantaggi-di-unidentificazione-precoce/ 2024-06-21T10:34:49+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Progressione-sclerosi-multipla.jpg https://neuroinfo.it/news/ocrelizumab-per-via-sottocutanea-arriva-il-via-libera-della-commissione-europea/ 2024-06-28T08:16:55+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Ocrelizumab-per-via-sottocutanea.jpg https://neuroinfo.it/congresso/ean/2024/la-disoccupazione-e-ancora-un-problema-per-chi-soffre-di-epilessia/ 2024-06-30T15:43:44+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Epilessia-disoccupazione.jpg https://neuroinfo.it/speciale/neurodegenerative/gli-unmet-needs-nella-gestione-clinica-della-sclerosi-multipla/ 2024-07-01T12:26:27+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/unmet-needs-sclerosi-multipla.jpg https://neuroinfo.it/congresso/ean/2024/incubi-frequenti-possono-preannunciare-declino-cognitivo-e-demenza/ 2024-07-01T15:43:51+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/insonnia-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/smoldering-disease-e-infiammazione-acuta-nella-gestione-della-sclerosi-multipla/ 2024-07-08T07:47:21+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/Smoldering-disease-2.jpg https://neuroinfo.it/news/fisioterapia-psicoterapia-ed-educazione-alla-diagnosi-il-trattamento-del-disturbo-motorio-funzionale/ 2024-07-10T08:06:19+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/Trattamento-DMF.jpg https://neuroinfo.it/speciale/neurodegenerative/come-cambia-la-prevalenza-dei-fattori-di-rischio-per-la-demenza/ 2024-07-10T10:22:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/rischio-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/sclerosi-multipla-quando-sospettare-una-progressione-di-malattia/ 2024-07-17T09:27:36+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/Landi-sclerosi.jpg https://neuroinfo.it/congresso/aaic/2024/malattia-di-alzheimer-esami-ematochimici-per-la-diagnosi-precoce/ 2024-07-29T12:49:57+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/Test-ematochimici.jpg https://neuroinfo.it/congresso/aaic/2024/glp-1-ra-per-lalzheimer-da-aaic-2024-nuove-evidenze-su-liraglutide/ 2024-07-30T11:00:48+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/liraglutide.jpg https://neuroinfo.it/congresso/aaic/2024/lesposizione-al-fumo-di-incendi-aumenta-il-rischio-di-demenza/ 2024-07-31T08:42:20+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/Incendi-demenza.jpg https://neuroinfo.it/congresso/aaic/2024/un-consumo-eccessivo-di-carne-rossa-processata-potrebbe-aumentare-il-rischio-di-demenza/ 2024-07-31T13:31:32+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/carne-rossa-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/demenza-perdita-della-vista-e-colesterolo-aggiunti-alla-lista-dei-fattori-di-rischio-modificabili/ 2024-08-02T12:37:15+00:00 https://neuroinfo.it/wp-content/uploads/2024/08/demenza-rischio.jpg https://neuroinfo.it/speciale/ictus/rischio-di-demenza-nei-pazienti-con-complicanze-cardiovascolari-precoci-post-ictus/ 2024-09-06T12:36:48+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/demenza-ictus.jpg https://neuroinfo.it/speciale/neurodegenerative/nuove-evidenze-sul-legame-tra-disturbi-della-vista-e-demenza-negli-anziani/ 2024-09-12T08:45:23+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/vista-demenza-2.jpg https://neuroinfo.it/speciale/neurodegenerative/trapianto-di-microbiota-fecale-per-il-trattamento-del-parkinson/ 2024-09-12T15:16:06+00:00 https://neuroinfo.it/wp-content/uploads/2024/08/Trapianto-microbiota-fecale.jpg https://neuroinfo.it/speciale/neurodegenerative/malattia-di-alzheimer-le-ultime-novita-su-donanemab-e-lecanemab/ 2024-09-12T15:16:30+00:00 https://neuroinfo.it/wp-content/uploads/2024/08/donanemab-lecanemab.jpg https://neuroinfo.it/interviste/dovremmo-tutti-conoscere-e-allenare-il-cervello/ 2024-09-12T15:17:21+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/notizie-cervello.jpg https://neuroinfo.it/speciale/neurodegenerative/sclerosi-multipla-il-ruolo-della-smoldering-disease-nella-gestione-clinica/ 2024-09-12T15:18:18+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/Smoldering-disease.jpg https://neuroinfo.it/interviste/sulluso-terapeutico-della-neuromodulazione-dalle-dipendenze-alle-patologie-neurologiche/ 2024-09-12T15:19:27+00:00 https://neuroinfo.it/wp-content/uploads/2024/03/Neuromodulazione.jpg https://neuroinfo.it/wp-content/uploads/2024/03/unnamed-3-scaled.jpg https://neuroinfo.it/wp-content/uploads/2024/03/unnamed.jpg https://neuroinfo.it/interviste/sul-rapporto-tra-neuroscienze-e-psicoanalisi-da-freud-alla-scuola-psicomed/ 2024-09-12T15:19:48+00:00 https://neuroinfo.it/wp-content/uploads/2024/02/PSICOMED.jpg https://neuroinfo.it/speciale/epilessia/ridurre-gli-esami-inappropriati-per-le-crisi-convulsive-pediatriche/ 2024-09-12T15:23:54+00:00 https://neuroinfo.it/wp-content/uploads/2024/07/crisi-pediatriche-scaled.jpg https://neuroinfo.it/speciale/epilessia/european-epilepsy-congress-2024-a-roma-3-700-partecipanti-per-fare-il-punto-sull-epilessia/ 2024-09-13T07:05:11+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/EEC-2024.jpg https://neuroinfo.it/rubrica/ritratti/un-caffe-con-giuseppe-micieli/ 2024-09-13T12:03:58+00:00 https://neuroinfo.it/wp-content/uploads/2024/01/Micieli-2-e1706625877774.png https://neuroinfo.it/wp-content/uploads/2024/01/Micieli-4.png https://neuroinfo.it/rubrica/head2head/amiloidosi-cardiaca-da-transtiretina-cardiologo-e-neurologo-a-confronto/ 2024-09-13T14:18:42+00:00 https://neuroinfo.it/wp-content/uploads/2023/09/neurology-ATTR.jpg https://neuroinfo.it/wp-content/uploads/2023/08/logo_cardioinfo-300x81.png https://neuroinfo.it/rubrica/ritratti/un-caffe-con-francesco-nonino/ 2024-09-18T09:33:21+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/Francesco-Nonino-Photo-credit-Viktor-Cap_OK-scaled.jpg https://neuroinfo.it/wp-content/uploads/2024/09/img056.jpg https://neuroinfo.it/news/neuromielite-ottica-aifa-approva-la-rimborsabilita-di-un-nuovo-trattamento/ 2024-09-20T07:35:29+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/iStock-1297313971.jpg https://neuroinfo.it/rubrica/head2head/atassia-di-friedreich-neurologo-e-cardiologo-a-confronto/ 2024-09-24T15:07:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/Atassia-di-Friedreich-H2H.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/news/emicrania-acuta-uno-studio-mette-a-confronto-i-trattamenti-disponibili/ 2024-09-25T07:47:26+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/iStock-958433426.jpg https://neuroinfo.it/news/cinema-come-cura-un-incontro-sul-valore-terapeutico-dei-film/ 2024-09-25T08:16:33+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/Cinema-come-cura.jpg https://neuroinfo.it/wp-content/uploads/2024/09/locandina-finale-a3-Neuro.png https://neuroinfo.it/speciale/atassia-di-friedreich/atassia-di-friedreich-patofisiologia-clinica-e-inquadramento-diagnostico/ 2024-09-25T08:56:48+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/Atassia-di-friedreich.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/speciale/ictus/ictus-lieve-e-tia-qual-e-la-durata-ottimale-della-dapt/ 2024-10-02T10:30:49+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/butterfly-scaled.jpg https://neuroinfo.it/speciale/neurodegenerative/giornata-mondiale-dellalzheimer-dalla-sin-un-appello-per-la-prevenzione/ 2024-10-04T07:48:08+00:00 https://neuroinfo.it/wp-content/uploads/2024/09/SIN.jpg https://neuroinfo.it/news/litalia-si-tinge-di-blu-per-la-giornata-della-neurologia/ 2024-10-04T08:21:41+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/iStock-2162991440.jpg https://neuroinfo.it/interviste/il-fenomeno-della-demenza-nella-popolazione-migrante/ 2024-10-07T12:39:39+00:00 https://neuroinfo.it/wp-content/uploads/2023/11/Immidem.jpg https://neuroinfo.it/news/lintervento-precoce-nei-disturbi-del-neurosviluppo-una-prospettiva-italiana/ 2024-10-09T12:15:00+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/iStock-1013629218.jpg https://neuroinfo.it/interviste/gestione-olistica-dellatassia-di-friedreich/ 2024-10-16T12:33:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/Gestione-olistia-Atassia-di-Friedreich.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/interviste/diagnosi-differenziale-dellatassia-di-friedreich-il-ruolo-del-test-genetico/ 2024-10-23T09:29:45+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/Atassia-test-genetico.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/news/emicrania-laifa-approva-la-rimborsabilita-di-atogepant/ 2024-10-23T13:11:11+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/iStock-186052580.jpg https://neuroinfo.it/interviste/sul-futuro-delle-residenze-sanitarie-assistenziali-rsa/ 2024-10-25T10:25:51+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/RSA.jpg https://neuroinfo.it/speciale/neurodegenerative/dalla-prevenzione-della-demenza-alla-prevenzione-nella-demenza/ 2024-10-29T11:25:15+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/prevenzione-terziaria-demenza.jpg https://neuroinfo.it/speciale/neurodegenerative/cliniche-della-memoria-una-proposta-per-un-approccio-innovativo/ 2024-10-29T11:51:24+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/clinichedella-memoria.jpg https://neuroinfo.it/speciale/ictus/ictus-ischemico-quando-iniziare-la-terapia-con-i-doac/ 2024-10-29T14:54:45+00:00 https://neuroinfo.it/wp-content/uploads/2024/10/DOAC-ictus.jpg https://neuroinfo.it/news/diagnosi-dellalzheimer-gli-esperti-delliwg-i-biomarcatori-non-bastano/ 2024-11-06T15:06:23+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/IGW-biomarcatori.jpg https://neuroinfo.it/news/miastenia-gravis-generalizzata-aifa-approva-ravulizumab-per-i-pazienti-positivi-agli-anticorpi-anti-achr/ 2024-11-08T08:53:15+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/miastenia-gravis.jpg https://neuroinfo.it/congresso/sin/2024/sin-2024-tutte-le-novita-dal-congresso/ 2024-11-11T12:00:36+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/iStock-2000275955-scaled.jpg https://neuroinfo.it/news/aifa-cambia-le-regole-per-il-trattamento-preventivo-dellemicrania/ 2024-11-12T13:00:09+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/AIFA-emicrania.jpg https://neuroinfo.it/interviste/sette-nuovi-farmaci-in-sei-anni-come-sta-cambiando-il-trattamento-dellemicrania/ 2024-11-15T10:22:52+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/trattamento-emicrania.jpg https://neuroinfo.it/interviste/epilessie-farmacoresistenti-una-speranza-dai-farmaci-di-terza-generazione/ 2024-11-15T11:29:52+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/epilessie-farmacoresistenti.jpg https://neuroinfo.it/interviste/quali-novita-dal-54-congresso-della-sin/ 2024-11-15T12:02:37+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/SIN-2024-scaled.jpeg https://neuroinfo.it/interviste/malattia-di-parkinson-fabrizio-stocchi-casi-raddoppiati-dal-1990-al-2015/ 2024-11-18T10:35:25+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/Parkinson-aumento.jpg https://neuroinfo.it/interviste/neuroimaging-per-la-diagnosi-precoce-della-malattia-di-alzheimer/ 2024-11-18T13:46:59+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/Neuroimaging-alzheimer.jpg https://neuroinfo.it/interviste/disturbo-comportamentale-del-sonno-rem-e-rischio-di-patologie-neurodegenerative/ 2024-11-19T15:46:03+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/Sonno-REM-patologie-neurodegenerative.jpg https://neuroinfo.it/news/alzheimer-ok-del-chmp-ema-alluso-di-lecanemab-ma-solo-in-casi-specifici/ 2024-11-22T10:13:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/lecanemab-CHMP.jpg https://neuroinfo.it/interviste/gestione-clinica-delle-emorragie-cerebrali-time-is-brain/ 2024-11-27T15:11:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/Time-is-brain.jpg https://neuroinfo.it/interviste/alzheimer-focus-su-metodiche-neurofisiologiche-e-neuromodulazione/ 2024-11-27T15:21:31+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/neuromodulazione.jpg https://neuroinfo.it/interviste/atassia-di-friedreich-burden-of-illness-e-qualita-di-vita/ 2024-12-04T09:34:42+00:00 https://neuroinfo.it/wp-content/uploads/2024/11/iStock-1432904524.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/interviste/linsonnia-cronica-e-un-disturbo-neurologico/ 2024-12-06T11:06:38+00:00 https://neuroinfo.it/wp-content/uploads/2024/12/insonnia-cronica.jpg https://neuroinfo.it/interviste/assistenza-infermieristica-in-neurologia-dalla-brain-health-al-telenursing/ 2024-12-11T11:56:12+00:00 https://neuroinfo.it/wp-content/uploads/2024/12/ANIN.jpg https://neuroinfo.it/interviste/la-neurologia-dellemergenza-urgenza-edizione-2024-quali-novita/ 2024-12-11T13:52:15+00:00 https://neuroinfo.it/wp-content/uploads/2024/12/Neurologia-dellemergenza-urgenza.jpg https://neuroinfo.it/speciale/neurodegenerative/alzheimer-mortalita-inferiore-tra-tassisti-e-autisti-di-ambulanza/ 2024-12-18T11:46:53+00:00 https://neuroinfo.it/wp-content/uploads/2024/12/Alzheimer-tassisti.jpg https://neuroinfo.it/speciale/ictus/trattamento-delledema-periematoma-limiti-attuali-e-prospettive/ 2024-12-18T13:42:00+00:00 https://neuroinfo.it/wp-content/uploads/2024/12/edema-periematoma.jpg https://neuroinfo.it/interviste/malattia-di-parkinson-gli-ultimi-dati-dal-congresso-sin/ 2025-01-08T15:54:41+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/iStock-2109207232-scaled.jpg https://neuroinfo.it/news/qual-e-laspettativa-di-vita-dopo-una-diagnosi-di-demenza/ 2025-01-09T13:50:42+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/aspettativa-di-vita-demenza.jpg https://neuroinfo.it/interviste/neuweek-2024-un-focus-sulle-cefalee/ 2025-01-13T11:47:41+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/iStock-179680401-scaled.jpg https://neuroinfo.it/interviste/ictus-cerebrale-limportanza-della-collaborazione-interdisciplinare-per-la-diagnosi/ 2025-01-15T08:33:32+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/iStock-497977529.jpg https://neuroinfo.it/news/tenecteplase-per-lictus-ischemico-acuto-i-risultati-dello-studio-chablis-t/ 2025-01-15T11:14:15+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/tenecteplase.jpg https://neuroinfo.it/news/parkinson-il-ruolo-di-mglu3-nellevoluzione-della-malattia/ 2025-01-23T10:10:30+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/iStock-925413082-scaled.jpg https://neuroinfo.it/news/malattia-di-huntington-segni-precoci-ventanni-prima-dei-sintomi/ 2025-01-28T13:03:29+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/Huntington.jpg https://neuroinfo.it/news/international-stroke-conference-2025-le-sessioni-late-breaking-science/ 2025-01-30T15:50:14+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/ISC25-lA.jpg https://neuroinfo.it/news/un-test-ematico-per-distinguere-ictus-ischemico-ed-emorragico-prima-dellarrivo-in-ospedale/ 2025-01-31T09:32:43+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/test-ematico-ictus.jpg https://neuroinfo.it/news/ictus-ischemico-propranololo-riduce-il-rischio-nelle-donne/ 2025-01-31T10:06:55+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/iStock-532117842-scaled.jpg https://neuroinfo.it/news/aumentare-lintensita-dellesercizio-nella-riabilitazione-post-ictus/ 2025-02-03T13:08:03+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/iStock-1188989963.jpg https://neuroinfo.it/news/ridurre-la-disabilita-post-ictus-nuovi-dati-sullefficacia-della-trombectomia/ 2025-02-06T08:47:01+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/iStock-1177149522-scaled.jpg https://neuroinfo.it/news/stimolazione-transcranica-corrente-diretta-per-una-migliore-ripresa-dallictus/ 2025-02-07T08:40:15+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/iStock-1147141160.jpg https://neuroinfo.it/news/allirccs-neuromed-un-nuovo-centro-per-lo-studio-e-la-cura-dellepilessia/ 2025-02-10T09:07:47+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/Neuromed-Centro-epilessia.jpg https://neuroinfo.it/news/giornata-internazionale-per-lepilessia-al-via-la-campagna-di-sensibilizzazione-di-fondazione-lice/ 2025-02-10T14:57:17+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/iStock-1595495625-scaled.jpg https://neuroinfo.it/news/trattamento-endovascolare-tenecteplase-un-nuovo-approccio-per-lictus-con-occlusione-dei-grandi-vasi/ 2025-02-10T15:40:27+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/tenecteplase-ictus-grandi-vasi.jpg https://neuroinfo.it/news/nuove-evidenze-sulla-relazione-tra-alzheimer-diabete-e-obesita/ 2025-02-12T11:17:19+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/Alzheimer-diabete-obesita.jpg https://neuroinfo.it/interviste/trustroke-lintelligenza-artificiale-nel-trattamento-dei-pazienti-con-ictus/ 2025-02-12T14:12:32+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/iStock-1164361496-scaled.jpg https://neuroinfo.it/wp-content/uploads/2025/02/eu_funded_en.jpg https://neuroinfo.it/news/sclerosi-multipla-aifa-approva-la-rimborsabilita-di-ublituximab/ 2025-02-17T09:45:06+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/sclerosi-multipla-uplituximab.jpg https://neuroinfo.it/news/demenza-dallo-studio-interceptor-un-modello-predittivo-per-la-diagnosi-precoce/ 2025-02-18T16:58:43+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/Interceptor-demenza.jpg https://neuroinfo.it/news/satralizumab-per-la-miastenia-gravis-achr-positiva-lo-studio-luminesce/ 2025-02-19T13:41:29+00:00 https://neuroinfo.it/wp-content/uploads/2025/02/satralizumab-miastenia.jpg https://neuroinfo.it/news/afasia-post-ictus-nuovi-dati-sullefficacia-della-rtms/ 2025-03-03T12:10:26+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/rTMS-.jpg https://neuroinfo.it/news/10-regole-per-una-corretta-comunicazione-della-diagnosi-di-mci-e-demenza/ 2025-03-03T16:29:10+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/comunicazione-diagnosi-demenza.jpg https://neuroinfo.it/news/lecanemab-lema-conferma-la-sua-scelta-la-parola-passa-alla-commissione-europea/ 2025-03-04T12:55:02+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/Lecanemab-EMA.jpg https://neuroinfo.it/news/libro-bianco-epilessia-lice-impatto-clinico-economico-e-sociale/ 2025-03-11T10:34:13+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-2170791644-scaled.jpg https://neuroinfo.it/interviste/libro-bianco-epilessia-focus-sui-progressi-clinici-e-le-prossime-sfide/ 2025-03-13T10:57:33+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/epilessia-sfide.jpg https://neuroinfo.it/interviste/cost-of-illness-epilessia-in-italia/ 2025-03-13T10:58:17+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-2166718294-scaled.jpg https://neuroinfo.it/news/lincremento-globale-della-malattia-di-parkinson-una-proiezione-al-2050/ 2025-03-17T14:01:29+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-2190912633-scaled.jpg https://neuroinfo.it/interviste/trattamento-dellemicrania-linee-guida-e-nuovi-obiettivi-terapeutici/ 2025-03-18T16:02:06+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/emicrania-linee-guida.jpg https://neuroinfo.it/interviste/emicrania-efficacia-clinica-di-galcanezumab-e-impatto-sulla-qualita-di-vita/ 2025-03-18T16:35:28+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-2187279553-scaled.jpg https://neuroinfo.it/news/emicrania-acuta-episodica-in-ambito-ambulatoriale-le-nuove-linee-guida-acp/ 2025-03-21T10:04:27+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/emicrania-linee-guida-ACP.jpg https://neuroinfo.it/interviste/galcanezumab-per-il-trattamento-dellemicrania-i-dati-real-world/ 2025-03-24T09:59:23+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/Galcanezumab-real-world.jpg https://neuroinfo.it/news/dalloms-il-nuovo-rapporto-gehm-sulla-demenza-tra-rifugiati-e-migranti/ 2025-03-26T11:11:37+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-1460187960-scaled.jpg https://neuroinfo.it/news/espansione-del-trial-proceed-per-la-prevenzione-dellemicrania/ 2025-04-03T15:05:45+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/iStock-1475328292-scaled.jpg https://neuroinfo.it/news/come-incidono-le-abitudini-del-sonno-sul-rischio-di-demenza/ 2025-04-09T15:10:39+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/iStock-2070745714-scaled.jpg https://neuroinfo.it/news/risultati-promettenti-per-inebilizumab-nella-miastenia-gravis-generalizzata/ 2025-04-15T10:13:58+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/miastenia-gravis--scaled.jpg https://neuroinfo.it/news/lecanemab-arriva-in-europa-ok-dalla-commissione-europea/ 2025-04-16T15:13:41+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/iStock-2167449385-scaled.jpg https://neuroinfo.it/news/lecanemab-esperti-preoccupati-dalla-decisione-dellema/ 2025-04-25T08:12:39+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/Lecanemab-EMA-Nonino.jpg https://neuroinfo.it/interviste/limportanza-della-tempestivita-nella-presa-in-carico-dei-pazienti-con-emicrania/ 2025-04-28T13:09:05+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/iStock-1211889059-scaled.jpg https://neuroinfo.it/news/trattamento-del-dolore-neuropatico-le-nuove-raccomandazioni-neupsig/ 2025-05-05T13:21:49+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/dolore-neuropatico.jpg https://neuroinfo.it/news/inquinamento-atmosferico-e-patologie-neurodegenerative-nuove-evidenze-da-due-studi-italiani/ 2025-05-09T11:35:20+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/iStock-1738380074.jpg https://neuroinfo.it/news/alleanza-per-la-miastenia-grave-un-modello-di-rete-per-le-malattie-rare/ 2025-05-13T16:51:37+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/iStock-1321193945.jpg https://neuroinfo.it/congresso/sno/2025/pasquale-palumbo-presidente-sno-al-centro-la-formazione/ 2025-05-16T07:13:17+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/iStock-1171987989.jpg https://neuroinfo.it/interviste/neuroscienze-cliniche-e-new-technologies-la-parola-ai-giovani/ 2025-05-20T08:44:02+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/Neuroscienze-cliniche-e-new-technologies.jpg https://neuroinfo.it/interviste/massimizzare-i-benefici-dei-nuovi-trattamenti-per-lemicrania/ 2025-05-20T09:21:15+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/trattamenti-emicrania.jpg https://neuroinfo.it/interviste/la-tossina-botulinica-nella-malattia-di-parkinson-e-nei-parkinsonismi/ 2025-05-22T09:50:24+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/Tossina-botulinica.jpg https://neuroinfo.it/congresso/sno/2025/sclerosi-multipla-trattamenti-precoci-e-ad-alta-efficacia-per-cambiare-la-storia-della-malattia/ 2025-05-27T07:41:24+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/iStock-1126686354.jpg https://neuroinfo.it/news/efgartigimod-alfa-per-la-polineuropatia-demielinizzante-infiammatoria-cronica-parere-positivo-dellema/ 2025-05-27T14:08:35+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/Polineuro.jpg https://neuroinfo.it/news/vutrisiran-per-lamiloidosi-attr-via-libera-allautosomministrazione/ 2025-05-28T09:40:33+00:00 https://neuroinfo.it/wp-content/uploads/2025/05/vutrisiran.jpg https://neuroinfo.it/news/neuroeconomia-quando-le-emozioni-guidano-le-decisioni-economiche/ 2025-06-05T12:24:25+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/Neuroeconomia.jpg https://neuroinfo.it/news/malattia-di-alzheimer-e-demenze-correlate-verso-un-aumento-delle-disuguaglianze/ 2025-06-10T12:45:42+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/iStock-2165239233.jpg https://neuroinfo.it/news/emicrania-oggi-liniziativa-liberi-dal-dolore-una-nuova-era-per-la-terapia-delle-cefalee/ 2025-06-19T07:34:16+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/Liberi-dal-dolore.jpg https://neuroinfo.it/news/hvr-durante-il-sonno-marker-precoce-per-ictus-depressione-e-disturbi-cognitivi/ 2025-06-24T08:26:38+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/iStock-1753896248.jpg https://neuroinfo.it/news/atassia-di-friedreich-una-rassegna-fa-il-punto-su-aspetti-diagnostici-clinici-e-assistenziali/ 2025-06-24T15:18:22+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/Atassia-di-friedreich-rassegna.jpg https://neuroinfo.it/news/neurofilamento-a-catena-leggera-snfl-un-biomarcatore-precoce-per-le-ricadute-di-sclerosi-multipla/ 2025-06-25T06:45:51+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/NFL-sclerosu-multipla.jpg https://neuroinfo.it/news/fremanezumab-dati-real-world-confermano-lefficacia-nella-gestione-dellemicrania/ 2025-06-25T06:46:51+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/franezumanb.jpg https://neuroinfo.it/news/polineuropatie-chatgpt-puo-aiutare-i-neurologi-non-specialisti-nella-diagnosi/ 2025-06-26T07:53:02+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/ChatGPT-polineuropatia.jpg https://neuroinfo.it/news/un-test-per-linsulino-resistenza-per-predire-la-progressione-dellalzheimer/ 2025-06-27T07:32:23+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/resistenza-insulina-AD.jpg https://neuroinfo.it/news/emicrania-nei-pazienti-che-soffrono-di-obesita-benefici-da-una-terapia-glp-1/ 2025-06-27T07:34:55+00:00 https://neuroinfo.it/wp-content/uploads/2025/06/iStock-938095766.jpg https://neuroinfo.it/news/eptinezumab-per-il-trattamento-dellemicrania-casi-clinici/ 2025-06-30T10:34:42+00:00 https://neuroinfo.it/wp-content/uploads/2025/03/Eptinezumab.jpg https://neuroinfo.it/speciale/epilessia/sindrome-di-lennox-gastaut-di-dravet-e-sclerosi-tuberosa-strategie-antiepilettiche-e-impatto-sul-ssn/ 2025-06-30T10:56:06+00:00 https://neuroinfo.it/wp-content/uploads/2024/05/Quaderno-Res.jpg https://neuroinfo.it/interviste/trauma-cranico-glasgow-coma-scale-e-nuovi-modelli-di-prognosi/ 2025-07-03T10:09:48+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/iStock-1389524080-scaled.jpg https://neuroinfo.it/news/farmaci-biologici-ucb-investe-5-miliardi-di-dollari-negli-stati-uniti/ 2025-07-09T07:53:01+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/UCM-biologici.jpg https://neuroinfo.it/interviste/zilucoplan-per-la-miastenia-grave-innovativita-ed-efficacia/ 2025-07-14T07:52:49+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/zilucoplan.jpg https://neuroinfo.it/news/lantipertensivo-migliore-per-ridurre-il-rischio-di-demenza/ 2025-07-15T15:03:54+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/antipertensivo.jpg https://neuroinfo.it/news/tenecteplase-per-lictus-acuto-i-trial-bridge-tnk-e-angel-tnk/ 2025-07-16T09:09:23+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/tenecteplase-ictus-acuto.jpg https://neuroinfo.it/news/encefalopatie-epilettiche-rare-strategie-innovative-per-la-transizione-dalleta-pediatrica-a-quella-adulta/ 2025-07-17T14:26:08+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/DEEstrategy.jpg https://neuroinfo.it/news/verso-una-definizione-standard-di-pira-nella-sclerosi-multipla/ 2025-07-21T11:05:04+00:00 https://neuroinfo.it/wp-content/uploads/2025/04/iStock-485193583-scaled.jpg https://neuroinfo.it/interviste/non-possiamo-piu-ignorare-le-differenze-di-genere-in-neurologia/ 2025-07-24T10:49:51+00:00 https://neuroinfo.it/wp-content/uploads/2025/07/differenze-di-genere-neurologia.jpg https://neuroinfo.it/news/risdiplam-per-la-sma-pre-sintomatica-i-risultati-dello-studio-rainbowfish/ 2025-08-26T08:48:40+00:00 https://neuroinfo.it/wp-content/uploads/2025/08/SMA.jpg https://neuroinfo.it/news/tossicita-finanziaria-nelle-malattie-neuromuscolari-un-problema-sottovalutato/ 2025-08-26T09:08:33+00:00 https://neuroinfo.it/wp-content/uploads/2025/08/tossicita-finanziaria.jpg https://neuroinfo.it/news/nuove-ipotesi-sulla-relazione-tra-uso-di-apparecchi-acustici-e-rischio-di-demenza/ 2025-08-26T09:12:56+00:00 https://neuroinfo.it/wp-content/uploads/2025/08/Apparecchi-acustici.jpg https://neuroinfo.it/news/tna-non-focali-attenzione-a-livello-di-istruzione-ed-eta-avanzata/ 2025-08-26T09:37:58+00:00 https://neuroinfo.it/wp-content/uploads/2025/08/TNA-non-focali.jpg https://neuroinfo.it/news/efgartigimod-una-nuova-speranza-per-la-miastenia-gravis-sieronegativa/ 2025-08-27T10:30:33+00:00 https://neuroinfo.it/wp-content/uploads/2025/08/miastenia-sieronegativa.jpg https://neuroinfo.it/news/trattamento-dellemicrania-acuta-come-cambia-la-pratica-clinica-alla-luce-delle-nuove-evidenze/ 2025-09-04T10:28:03+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/trattamento-emicrania-acuta.jpg https://neuroinfo.it/news/il-futuro-della-terapia-per-lalzheimer-un-approccio-multi-target-e-di-precisione/ 2025-09-04T13:40:08+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/futuro-terapia-Alzheimer.jpg https://neuroinfo.it/news/fondo-italiano-per-lalzheimer-e-le-demenze-le-attivita-e-i-risultati-del-triennio-2021-2023/ 2025-09-09T11:22:03+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/Fondo-Alzheimer-e-demenze.jpg https://neuroinfo.it/news/disturbi-neurologici-funzionali-lappello-della-sin/ 2025-09-16T07:13:59+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/iStock-1432460063.jpg https://neuroinfo.it/news/autismo-paracetamolo-e-vaccini-la-posizione-della-sinpia/ 2025-09-24T09:54:35+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/SINPIA.jpg https://neuroinfo.it/speciale/atassia-di-friedreich/fa-on-the-road-1-fondazione-irccs-istituto-neurologico-carlo-besta/ 2025-09-29T07:13:25+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/FA-ontheroad_Besta_ThumbOK.png https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/news/smoldering-neuroinflammation-una-nuova-prospettiva-nella-gestione-clinica-della-sclerosi-multipla/ 2025-09-29T11:20:08+00:00 https://neuroinfo.it/wp-content/uploads/2025/01/Smoldering-neuroinflammation.jpg https://neuroinfo.it/interviste/oltre-lamiloide-nuovi-target-e-vie-terapeutiche-per-la-malattia-di-alzheimer/ 2025-09-29T13:02:13+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/iStock-1060874950.jpg https://neuroinfo.it/interviste/nmosd-modificare-il-paradigma-tra-attivita-di-malattia-e-relapse/ 2025-10-01T07:17:22+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/maxresdefault.jpg https://neuroinfo.it/news/i-musicisti-provano-dolore-in-modo-diverso-dagli-altri/ 2025-10-01T14:33:36+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/musicisti-dolore.jpg https://neuroinfo.it/news/progressione-nella-sclerosi-multipla-evidenze-ed-esperienze-cliniche/ 2025-10-02T08:55:21+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/iStock-2165317860.jpg https://neuroinfo.it/news/demenza-e-disuguaglianze-educative-uno-studio-italiano-su-incidenza-e-uso-di-risorse/ 2025-10-02T09:33:04+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/demenza-istruzione.jpg https://neuroinfo.it/news/un-dialogo-epigenetico-una-possibile-via-per-prevenire-lalzheimer/ 2025-10-06T14:44:40+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/dialogo-epigenetico.jpg https://neuroinfo.it/news/gene-editing-per-lattrv-pn-una-sola-infusione-riduce-del-90-la-transtiretina-mutata/ 2025-10-13T08:33:13+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/gene-editing.jpg https://neuroinfo.it/speciale/atassia-di-friedreich/episodio-2-policlinico-g-martino-messina/ 2025-10-14T14:54:08+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/Messina-thumb.png https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/news/parkinson-disponibile-in-italia-la-prima-apomorfina-sublinguale-per-il-trattamento-degli-episodi-off/ 2025-10-20T10:34:23+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/Parkinson-OFF.jpg https://neuroinfo.it/news/il-sonno-come-barriera-biologica-alla-neurodegenerazione/ 2025-10-30T13:24:56+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/Sonno-neurodegenerazione.jpg https://neuroinfo.it/interviste/rozanolixizumab-nei-pazienti-con-miastenia-gravis-le-novita-dal-congresso-sin-2025/ 2025-10-30T14:19:42+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/iStock-2151683232.jpg https://neuroinfo.it/news/agonisti-di-glp-1-e-alzheimer-dal-razionale-biologico-ai-primi-studi-clinici/ 2025-10-31T10:46:40+00:00 https://neuroinfo.it/wp-content/uploads/2025/09/GLP-1-Alzheimer.jpg https://neuroinfo.it/news/malattia-di-alzheimer-nuovi-orizzonti-terapeutici-dallasse-infiammazione-glp-1/ 2025-10-31T10:51:01+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/SIN-Novo.jpg https://neuroinfo.it/news/alzheimer-quanti-sono-i-pazienti-candidabili-alle-terapie-anti-amiloide-in-italia/ 2025-11-03T10:28:32+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/alzheimer-terapie-anti-amiloide.jpg https://neuroinfo.it/interviste/tenecteplase-e-non-solo-le-novita-nella-rivascolarizzazione-dellictus-ischemico-acuto/ 2025-11-10T12:03:58+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/prato-della-valle.jpg https://neuroinfo.it/news/cure-palliative-in-neurologia-la-sin-sollecita-fondi-mirati-e-standard-specifici/ 2025-11-11T11:06:36+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/SIN-cure-palliative.jpg https://neuroinfo.it/interviste/emicrania-e-disturbi-del-sonno-nuove-evidenze-cliniche/ 2025-11-12T08:35:01+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-106467367.jpg https://neuroinfo.it/interviste/progressione-nella-malattia-di-parkinson-quali-differenze-tra-uomini-e-donne/ 2025-11-12T09:01:12+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-517445579.jpg https://neuroinfo.it/interviste/progressione-invisibile-nella-sclerosi-multipla-cogliere-i-segnali-che-precedono-la-disabilita/ 2025-11-12T11:53:16+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/progressione-sclero-multiipla.jpg https://neuroinfo.it/wp-content/uploads/2025/11/211125-SANOFI-LOGO-RGB-e1762358181916.jpg https://neuroinfo.it/interviste/miastenia-gravis-con-anticorpi-anti-musk-lefficacia-terapeutica-di-rozanolixizumab/ 2025-11-13T09:39:49+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-1253260415.jpg https://neuroinfo.it/interviste/zilucoplan-nella-miastenia-gravis-generalizzata-dati-di-efficacia-nei-pazienti-anti-achr/ 2025-11-13T09:40:33+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-1481212368.jpg https://neuroinfo.it/blog/55-congresso-nazionale-sin-lo-speciale/ 2025-11-13T10:04:47+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/SIN-2025-header.png https://neuroinfo.it/interviste/biomarcatori-ematici-nella-malattia-di-alzheimer-il-ruolo-di-p-tau-217/ 2025-11-13T11:59:00+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-178523454.jpg https://neuroinfo.it/news/miastenia-gravis-in-sardegna-una-prevalenza-record-dati-criticita-e-prospettive/ 2025-11-17T08:50:38+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/miastenia-gravis-sardegna.jpg https://neuroinfo.it/news/miastenia-gravis-il-paradigma-delle-sfide-assistenziali-nelle-malattie-rare/ 2025-11-17T10:03:18+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-2193627310.jpg https://neuroinfo.it/interviste/riconsiderare-gli-endpoint-nei-trial-per-la-sclerosi-multipla/ 2025-11-17T13:43:31+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/iStock-1264444908.jpg https://neuroinfo.it/news/semaglutide-orale-non-rallenta-la-progressione-dellalzheimer-negli-studi-di-fase-3-evoke-ed-evoke/ 2025-11-25T09:15:46+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/semaglutide-alzheimer.jpg https://neuroinfo.it/interviste/clinical-cases-2-nmosd-misdiagnosis-quando-il-dosaggio-anticorpale-fa-la-differenza/ 2025-11-27T11:05:27+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/maxresdefault.jpg https://neuroinfo.it/rubrica/clinical-cases/un-caso-di-neuromielite-ottica-acquaporina-positivo-nmosd/ 2025-12-01T10:44:17+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/maxresdefault.jpg https://neuroinfo.it/news/demenze-tra-nuovi-farmaci-e-vecchie-diseguaglianze-il-nodo-irrisolto-dei-servizi/ 2025-12-01T13:20:34+00:00 https://neuroinfo.it/wp-content/uploads/2025/12/demenza-servizi.jpg https://neuroinfo.it/interviste/monitorare-e-preservare-la-salute-del-cervello/ 2025-12-15T09:07:40+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/Brain-HealthForloni.jpg https://neuroinfo.it/speciale/atassia-di-friedreich/episodio-4-ospedale-pediatrico-bambino-gesu-roma-san-paolo-e-palidoro/ 2025-12-16T13:09:05+00:00 https://neuroinfo.it/wp-content/uploads/2025/12/FA-ontheroad_Bambino-Gesu_Thumb-ok-scaled.png https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/speciale/atassia-di-friedreich/episodio-3-irccs-eugenio-medea-conegliano-veneto-e-pieve-di-soligo/ 2025-12-16T13:19:00+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/Medea-thumb-OK.png https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/news/robotica-sociale-e-ai-incarnata-verso-un-nuovo-paradigma-di-cure-neurologiche/ 2025-12-17T09:14:25+00:00 https://neuroinfo.it/wp-content/uploads/2025/12/iStock-2222309884.jpg https://neuroinfo.it/interviste/nmsod-integrare-comorbilita-e-preferenze-del-pazientenella-scelta-terapeutica/ 2025-12-17T09:20:50+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/BellomoYT.jpg https://neuroinfo.it/news/il-ritmo-riposo-attivita-come-possibile-segnale-precoce-di-demenza/ 2026-01-08T13:43:35+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/Ritmo-demenza.jpg https://neuroinfo.it/news/trattamenti-per-ladhd-una-review-fa-il-punto-su-benefici-rischi-e-qualita-delle-evidenze/ 2026-01-09T09:19:03+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/iStock-1250268258.jpg https://neuroinfo.it/news/fremanezumab-efficace-anche-nellemicrania-pediatrica/ 2026-01-21T09:29:39+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/Fremanezumab.jpg https://neuroinfo.it/news/trial-clinici-in-neurologia-cosa-aspettarsi-nei-primi-mesi-del-2026/ 2026-01-21T09:31:26+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/Trial-clinici-2026.jpg https://neuroinfo.it/news/ublituximab-e-terapia-anti-cd20-nella-sclerosi-multipla-online-il-libro-di-massimiliano-di-filippo-e-diego-centonze/ 2026-01-21T14:23:43+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/Senza-titolo-1.png https://neuroinfo.it/news/il-vaccino-per-lherpes-zoster-potrebbe-davvero-ridurre-il-rischio-di-demenza/ 2026-01-26T09:53:39+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/herpes-zoster-demenza.jpg https://neuroinfo.it/interviste/le-sfide-della-neurologia-territoriale/ 2026-01-29T14:05:58+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/neurologia-territoriale.jpg https://neuroinfo.it/news/caffe-te-e-rischio-di-demenza-cosa-dice-lo-studio-pubblicato-sul-jama/ 2026-02-11T11:09:22+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/demenza-caffe.jpg https://neuroinfo.it/news/giornata-internazionale-dellepilessia-oltre-il-controllo-delle-crisi-per-migliorare-la-qualita-di-vita/ 2026-02-11T16:09:40+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/iStock-1004111668.jpg https://neuroinfo.it/news/ictus-ischemico-aggiornamento-2026-delle-raccomandazioni-aha-asa/ 2026-02-13T09:32:36+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/iStock-147041675.jpg https://neuroinfo.it/news/cntb-su-immidem-la-nuova-batteria-europea-per-la-valutazione-neuropsicologica-cross-culturale/ 2026-02-17T15:33:10+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/immidem-scala.jpg https://neuroinfo.it/news/omaveloxolone-il-primo-trattamento-per-latassia-di-friedreich/ 2026-02-19T10:00:58+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/atassia-AIFA.jpg https://neuroinfo.it/interviste/il-ruolo-dei-neurofilamenti-nella-gestione-clinica-della-sclerosi-multipla/ 2026-02-19T11:04:40+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/Neurofilamenti-Centonze.jpg https://neuroinfo.it/news/dalle-bande-oligoclonali-al-%ce%ba-index-levoluzione-dei-biomarcatori-nella-sclerosi-multipla/ 2026-02-24T08:54:22+00:00 https://neuroinfo.it/wp-content/uploads/2026/02/biomarcatori-sclerosi-multipla.jpg https://neuroinfo.it/interviste/atassie-genetiche-diagnosi-mirata-e-nuove-prospettive-terapeutiche/ 2026-02-24T10:05:34+00:00 https://neuroinfo.it/wp-content/uploads/2025/11/iStock-182861490.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/interviste/neurofilamenti-nella-sclerosi-multipla-dalla-ricerca-alla-pratica-clinica/ 2026-03-03T10:00:12+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Neurofilamenti-sclerosi-multipla-Bernardini.jpg https://neuroinfo.it/news/nuove-evidenze-sulla-complessa-relaziona-tra-fumo-e-malattia-di-parkinson/ 2026-03-03T10:39:20+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Fumo-parkinson.jpg https://neuroinfo.it/news/sindrome-di-dravet-risultati-promettenti-per-zorevunersen-in-bambini-e-adolescenti/ 2026-03-09T08:31:19+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Dravet-.jpg https://neuroinfo.it/news/cervello-neuroscienze-e-invecchiamento-al-centro-del-vatican-longevity-summit-2026/ 2026-03-10T10:47:00+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Vatican-Longevity-Summit.jpg https://neuroinfo.it/news/i-dati-sulla-prevalenza-della-demenza-in-europa-mostrano-una-crescita-netta/ 2026-03-10T11:56:54+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Alzheimer-Europe.jpg https://neuroinfo.it/news/lesioni-del-midollo-spinale-nellanziano-recupero-neurologico-preservato-ma-nuove-sfide-per-la-riabilitazione/ 2026-03-16T13:08:43+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/lesione-midollo.jpg https://neuroinfo.it/news/nuove-prospettive-terapeutiche-nellepilessia-dalle-terapie-cellulari-ai-farmaci-sui-canali-ionici/ 2026-03-17T08:30:23+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/epilessia-nuove-prospettive.jpg https://neuroinfo.it/news/snfl-nella-sclerosi-multipla-dal-biomarcatore-alla-decisione-clinica/ 2026-03-17T10:08:55+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/sNfL-SM.jpg https://neuroinfo.it/speciale/neurodegenerative/biomarcatori-ematici-nellalzheimer-il-position-paper-sin-sibioc-sindem/ 2026-03-24T10:08:21+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/Biomarcatori-ematici-Alzheimer.jpg https://neuroinfo.it/interviste/gestione-terapeutica-di-un-paziente-naive-con-nmosd-aqp4-candidato-a-terapia-disease-modifying/ 2026-03-24T10:49:38+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/maxresdefault.jpg https://neuroinfo.it/news/cresce-il-rifiuto-delliniezione-di-vitamina-k-alla-nascita/ 2026-03-24T11:39:21+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/chicago.jpg https://neuroinfo.it/news/neurofilamenti-nella-sclerosi-multipla-il-31-marzo-il-workshop-a-roma/ 2026-03-30T13:21:51+00:00 https://neuroinfo.it/wp-content/uploads/2026/01/NeurofilamentiSM_31-marzo_DEM-1.png https://neuroinfo.it/interviste/tre-obiettivi-per-migliorare-i-servizi-italiani-per-la-demenza/ 2026-04-01T14:58:24+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/demenza-italia.jpg https://neuroinfo.it/news/progetto-immidem-verso-modelli-di-cura-inclusivi-per-la-demenza-nelle-popolazioni-migranti/ 2026-04-13T13:01:19+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/immidem-convegno-finale.jpg https://neuroinfo.it/news/cenobamato-il-prac-rafforza-le-raccomandazioni-su-monitoraggio-e-gestione-del-rischio-di-danno-epatico/ 2026-04-14T07:23:32+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/celobamato.jpg https://neuroinfo.it/interviste/sclerosi-multipla-quale-ruolo-per-i-biomarcatori-nella-pratica-clinica/ 2026-04-14T10:19:44+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/Centonze-neurofilamenti.jpg https://neuroinfo.it/news/trial-tempo-1-tavapadon-migliora-i-sintomi-motori-nel-parkinson-precoce/ 2026-04-16T08:45:19+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/tava-parkinson.jpg https://neuroinfo.it/news/ottantanni-de-il-pensiero-scientifico-editore-al-via-le-iniziative-per-il-2026/ 2026-04-16T12:41:51+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/Card-lancio-1-300x600-1.png https://neuroinfo.it/interviste/neurofilamenti-a-catena-leggera-applicazioni-e-criticita-nella-pratica-clinica-neurologica/ 2026-04-20T07:21:44+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/biomarcatori-SM.jpg https://neuroinfo.it/news/attr-cm-funzionalita-atriale-sinistra-per-stimare-il-rischio-di-ictus-anche-in-ritmo-sinusale/ 2026-04-20T10:35:03+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/ATTR-CM-Porcari.jpg https://neuroinfo.it/interviste/workshop-neurofilamenti-nella-sclerosi-multipla-il-racconto-della-giornata/ 2026-04-22T07:40:28+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/slide-tappo-scaled.jpg https://neuroinfo.it/news/donne-con-epilessia-maternita-e-lavoro-tra-barriere-sociali-e-gestione-clinica-personalizzata/ 2026-04-22T12:37:19+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/donne-eoilessia.jpg https://neuroinfo.it/congresso/aan/2026/gabapentin-dopo-lesione-traumatica-cerebrale-dati-real-world-mostrano-un-beneficio-su-cognizione-e-mortalita/ 2026-04-29T09:49:02+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/gabapentin.jpg https://neuroinfo.it/news/farmaci-anti-amiloide-per-lalzheimer-cosa-dicono-le-prove-il-webinar-aie-associali/ 2026-04-29T10:24:55+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/webinar-alzheimer.jpg https://neuroinfo.it/news/mci-o-alzheimer-precoce-una-revisione-cochrane-boccia-gli-anticorpi-anti-amiloide/ 2026-04-29T12:06:53+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/revisione-cochrane.jpg https://neuroinfo.it/interviste/neurofilamenti-e-sclerosi-multipla-dalle-evidenze-alle-applicazioni-cliniche/ 2026-04-29T13:16:35+00:00 https://neuroinfo.it/wp-content/uploads/2026/04/Neurofilamenti-sclerosi-multipla.jpg https://neuroinfo.it/speciale/neurofilamenti-nella-sm/neurodegenerative/neurofilamenti-nella-sclerosi-multipla-stratificazione-e-monitoraggio-della-malattia/ 2026-05-06T07:56:59+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/Neurofilamenti-Mirabella.jpg https://neuroinfo.it/news/progetto-prev-ita-dem-fattori-di-rischio-modificabili-e-traiettorie-del-declino-cognitivo/ 2026-05-18T14:35:04+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/PREV-ITA-DEM.jpg https://neuroinfo.it/news/liste-dattesa-in-neurologia-la-sin-pubblica-raccomandazioni-per-lappropriatezza-della-prima-visita/ 2026-05-21T09:07:20+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/liste-di-attesa-neurologia.jpg https://neuroinfo.it/speciale/neurodegenerative/per-trattare-davvero-lalzheimer-dobbiamo-prima-capirlo-meglio/ 2026-05-27T11:11:58+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/Sudhof.jpg https://neuroinfo.it/interviste/miastenia-gravis-generalizzata-instabilita-clinica-e-ruolo-di-rozanolixizumab/ 2026-05-28T10:41:19+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/Iorio.jpg https://neuroinfo.it/interviste/deficit-di-tk2-red-flags-cliniche-e-diagnosi-differenziale/ 2026-05-28T10:45:15+00:00 https://neuroinfo.it/wp-content/uploads/2026/05/garone.jpg https://neuroinfo.it/news/a-reggio-calabria-il-65-congresso-sno/ 2026-06-05T11:50:27+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/iStock-1219200718.jpg https://neuroinfo.it/interviste/congresso-nazionale-sno-2026-focus-su-evidenze-scientifiche-e-sicurezza-delle-cure/ 2026-06-08T15:01:26+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/iStock-2213221075.jpg https://neuroinfo.it/interviste/sclerosi-multipla-nelle-donne-strategie-terapeutiche-personalizzate-nelle-diverse-fasi-della-vita/ 2026-06-10T10:45:54+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/iStock-2158050921-scaled.jpg https://neuroinfo.it/interviste/utilizzo-di-dati-omici-e-machine-learning-nella-diagnosi-e-prognosi-delle-patologie-neurologiche/ 2026-06-11T12:32:09+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/iStock-515374716-scaled.jpg https://neuroinfo.it/news/neglect-spaziale-post-ictus-dalla-linea-guida-alla-pratica-clinica/ 2026-06-23T13:23:26+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/Neglect.jpg https://neuroinfo.it/news/epilessia-e-ipoacusia-dagli-apparecchi-acustici-un-possibile-effetto-protettivo-sul-rischio-di-demenza/ 2026-06-26T22:05:21+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/epilessia-ipoacusia.jpg https://neuroinfo.it/news/test-pupillare-di-13-secondi-per-prevedere-il-recupero-della-coscienza-dopo-grave-lesione-cerebrale/ 2026-06-27T22:05:25+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/test-pupillare.jpg https://neuroinfo.it/news/sclerosi-multipla-limpatto-oltre-i-sintomi-colpite-vita-sociale-e-lavoro/ 2026-06-27T22:05:55+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/sclerosi-multipla-vita-sociale.jpg https://neuroinfo.it/news/sclerosi-multipla-secondariamente-progressiva-via-libera-europeo-a-tolebrutinib-per-rallentare-la-disabilita/ 2026-06-25T13:20:31+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/tolebrutinib.jpg https://neuroinfo.it/blog/congresso-nazionale-sno-2026/ 2026-06-30T10:24:49+00:00 https://neuroinfo.it/wp-content/uploads/2026/06/SNO-2026.jpg https://neuroinfo.it/interviste/riconoscere-il-passaggio-alla-forma-progressiva-di-sm-per-prevenire-la-disabilita/ 2026-07-02T10:01:07+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-2266294918.jpg https://neuroinfo.it/interviste/sm-progressiva-standard-condivisi-e-attenzione-agli-aspetti-fondamentali-per-la-qualita-di-vita/ 2026-07-02T10:16:08+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-591998946.jpg https://neuroinfo.it/interviste/sclerosi-multipla-domande-mirate-per-rilevare-una-progressione-invisibile/ 2026-07-02T10:16:43+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-2230570326.jpg https://neuroinfo.it/interviste/sclerosi-multipla-nuovi-marker-per-riconoscere-la-progressione/ 2026-07-02T10:33:06+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-2241237219-scaled.jpg https://neuroinfo.it/interviste/nuovi-trattamenti-per-il-controllo-della-progressione-nei-pazienti-con-sclerosi-multipla/ 2026-07-02T10:42:39+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-2281465757.jpg https://neuroinfo.it/interviste/identificare-precocemente-la-progressione-nella-sclerosi-multipla-per-migliorare-gli-esiti-clinici/ 2026-07-02T10:45:05+00:00 https://neuroinfo.it/wp-content/uploads/2025/12/iStock-1352174546.jpg https://neuroinfo.it/interviste/oltre-ledss-quando-e-il-momento-giusto-per-intervenire/ 2026-07-02T10:45:40+00:00 https://neuroinfo.it/wp-content/uploads/2026/03/EDSS.jpg https://neuroinfo.it/interviste/accumulo-di-disabilita-nel-paziente-con-sm-quando-il-peggioramento-sfugge-al-controllo-clinico/ 2026-07-02T10:48:21+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-1417309119.jpg https://neuroinfo.it/interviste/monitorare-levoluzione-dellatassia-di-friedreich/ 2026-07-02T12:35:16+00:00 https://neuroinfo.it/wp-content/uploads/2025/10/iStock-914637098.jpg https://neuroinfo.it/wp-content/uploads/2024/09/Biogen_Logo_Standard.png https://neuroinfo.it/speciale/neurodegenerative/come-valutare-la-progressione-di-malattia-nel-paziente-con-sclerosi-multipla/ 2026-07-02T12:35:26+00:00 https://neuroinfo.it/wp-content/uploads/2024/06/progression.jpg https://neuroinfo.it/news/microbiota-e-neurodegenerazione-lintestino-si-conferma-un-possibile-snodo-precoce-della-malattia-neurologica/ 2026-07-08T12:47:24+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/microbiota.jpg https://neuroinfo.it/news/atrofia-muscolare-spinale-la-commissione-europea-estende-onasemnogene-abeparvovec-a-bambini-dai-2-anni-in-su/ 2026-07-10T08:18:51+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-1286225311-scaled.jpg https://neuroinfo.it/news/neurofilamenti-e-%ce%ba-index-nella-sclerosi-multipla-verso-una-stratificazione-biologica-di-diagnosi-prognosi-e-monitoraggio-terapeutico/ 2026-07-10T10:45:35+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/iStock-663390582.jpg https://neuroinfo.it/wp-content/uploads/2026/03/sh_logo_rgb-no-sfondo-scaled.png https://neuroinfo.it/news/nuovi-dati-sugli-effetti-neurologici-del-calcio-professionistico/ 2026-07-17T10:57:13+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/calciatori.jpg https://neuroinfo.it/news/alzheimer-la-p-tau217-nel-sangue-potrebbe-predire-il-declino-cognitivo-anni-prima-dei-sintomi/ 2026-07-17T11:04:17+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/ptau217.jpg https://neuroinfo.it/news/demenza-avanzata-thc-e-cbd-riducono-rapidamente-lagitazione-nel-trial-libby/ 2026-07-17T11:11:59+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/thc-cbd.jpg https://neuroinfo.it/news/la-neurologia-italiana-punta-su-prevenzione-innovazione-e-presa-in-carico-lungo-tutto-larco-della-vita/ 2026-07-20T13:18:16+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/Giornata-neurologia.jpg https://neuroinfo.it/news/alzheimer-colpire-la-tau-puo-rallentare-il-declino-cognitivo-i-dati-dello-studio-celia-su-diranersen/ 2026-07-22T08:23:51+00:00 https://neuroinfo.it/wp-content/uploads/2026/07/Direnersen.jpg https://neuroinfo.it/news/pm2-5-da-incendi-associato-a-un-aumento-degli-accessi-in-pronto-soccorso-per-emicrania-e-cefalee-primarie/ 2026-08-24T10:37:45+00:00 https://neuroinfo.it/wp-content/uploads/2026/08/incendi-emicrania.jpg https://neuroinfo.it/news/encefalopatia-traumatica-cronica-negli-ex-giocatori-nfl-prevalenza-elevata-e-legame-con-la-demenza/ 2026-08-25T15:22:22+00:00 https://neuroinfo.it/wp-content/uploads/2026/08/NFL-traumi.jpg https://neuroinfo.it/news/alzheimer-orexina-e-sonno-nrem-le-oscillazioni-notturne-potrebbero-indicare-una-riserva-di-resilienza-cerebrale/ 2026-08-26T10:33:55+00:00 https://neuroinfo.it/wp-content/uploads/2026/08/sonno-alzheimer.jpg https://neuroinfo.it/news/esposizione-paterna-a-valproato-prima-del-concepimento-studio-taiwanese-non-rileva-aumento-del-rischio-nei-figli/ 2026-08-26T11:02:47+00:00 https://neuroinfo.it/wp-content/uploads/2026/08/esposizione-paterna-valproato.jpg https://neuroinfo.it/news/parkinson-in-europa-un-costo-sociale-da-228-miliardi-di-euro-lanno/ 2026-08-28T03:00:20+00:00 https://neuroinfo.it/wp-content/uploads/2026/08/Parkinson-europa.jpg